3 Major Problems With Medicare Every Retiree Should Know About

Medicare presents notable retirement-cost risks: while Part A is generally premium-free, Part B and supplemental plans (Part D, Medicare Advantage) carry premiums that can rise, and Original Medicare has no annual out-of-pocket maximum, leaving retirees exposed to large bills from serious illness. Key gaps—dental, vision, hearing aids and long-term custodial care—mean investors and planners should factor Medicare shortfalls into retirement cash-flow modeling and consider mitigants such as Medigap, HSAs, increased savings and long-term-care insurance when setting asset allocation and liability plans.

Analysis

Market structure: Private-pay gaps in Medicare (no OOP max, uncovered services, premium volatility) shift demand toward Medicare Advantage, Medigap and HSA custodians — beneficiaries will favor capitated, bundled plans and pre-funded HSA solutions. Winners: large MA/insurers (UNH, CVS/AET, HUM), HSA custodians (HQY), and senior-housing REITs that can capture private-pay care (WELL, VTR); losers: providers with high uncompensated exposure and standalone long-term care operators lacking pricing power. Expect insurers to gain pricing power over the next 12–36 months as aging cohorts scale enrollment and seek downside protection.

Risk assessment: Primary tail risks are regulatory (CMS rate cuts, MA payment reforms, drug-price negotiation) and political (2024–2026 reconciliation bills) that could compress insurer margins by >100–300bps; operational tails include concentrated enrollment shifts during Open Enrollment causing short-term claim volatility. Immediate effects (days–weeks) center on sentiment around CMS guidance and enrollment data; short-term (3–12 months) on premium resets and Medigap demand; long-term (1–5 years) on demographic-driven demand and interest-rate sensitivity of REITs and annuity products. Hidden dependency: employer retiree-plan behavior and HSA tax-rule changes can quickly reroute flows.

trade implications: Tactical: establish modest, diversified exposure to MA/Medigap winners and HSA custodians while hedging regulatory risk. Prefer 6–12 month call spreads on UNH/CVS for enrollment upside and 12–36 month core holds in HQY and WELL for structural inflows into HSAs and senior housing. Use short-dated put protection around CMS announcement windows (30–90 days) and favor pair trades that long insurers vs short highly leveraged nursing-home operators or hospital REITs (e.g., long UNH, short MPW) to neutralize macro rate effects.

contrarian angles: Consensus underestimates HSA custodians’ revenue leverage — a 10–20% shift from cash to HSA balances could grow custodial fees by >15%/yr over three years; conversely, the market may be underpricing a regulatory shock that trims MA profits. Historical parallel: MA expansion post-ACA saw durable enrollee migration; however, concentrated regulatory scrutiny followed — position sizes should assume a 20–30% volatility spike around policy events. Unintended consequence: accelerating MA penetration can trigger antitrust/anti‑overpayment backlash, creating 6–12 month sellable drawdowns.

Key Decisions for Investors

• Establish a 1.5–2.5% long position in UnitedHealth Group (UNH) via 6–12 month call spreads (buy ATM call, sell 25–35% OTM call) to capture Open Enrollment and MA share gains; size to risk no more than 0.5% portfolio loss if spread fails.
• Allocate 1–1.5% core position to HealthEquity (HQY) common stock to play HSA balance growth (12–36 month hold); add if AUM growth prints >10% YoY or HSA flows accelerate after a CMS or IRS guidance change.
• Take a 1% short position in Medical Properties Trust (MPW) or similarly leveraged healthcare REITs (via inverse ETF or outright short) for 3–12 months to hedge interest-rate and senior-housing occupancy risks; cover on signs of improved occupancy (+200bps over two consecutive quarters).
• Implement downside protection: buy 90–120 day puts (or collars) on UNH/CVS sized to limit drawdown to 10–12% ahead of key CMS payment announcements (watch windows in next 30–90 days).
• If CMS publishes MA payment cuts >150bps or Congress advances drug-price negotiation in next 6 months, reduce insurer exposure by 50% and rotate 1–2% into senior-housing REITs (WELL/VTR) and diversified healthcare services that benefit from private-pay demand.